Challenging the Status Quo

Dear ANRF partner!

The challenges presented by Arthritis and associated Autoimmune Diseases are formidable and diverse. According to the CDC, 25.9 % of the adult population in the US will be diagnosed with Arthritis by 2040. Arthritis is also the top reason for medical discharge from service in the military, and the leading cause of disability among veterans and service members. In 2013 alone, the cost of arthritis-attributable medical expenditures and lost wages among US adults stood at an astonishing $303.5 billion. Clearly, the heavy burden of this disease on our economy, national security and quality of life cannot be overstated.

At ANRF, we are mindful of these realities and cognizant of the size of this foe. Undaunted, we work...

Our 2017/18 Annual Report is out!

Pleased to share the 2017/18 Annual Report summarizing our financial strength, scientific progress, organization news and exciting new programs.

First in Human - New Immune Therapy Enters Clinical Trials

Scientific Advisory Board Chair, Dr. Carl Ware, and Lilly Pharmaceutical announced the start of a new Immunotherapy clinical trial with great promise for autoimmune diseases.

Helpful Arthritis, Rheumatology and Autoimmune Diseases Fact Sheets

A Fact Sheet library has been made available as part of a larger plan to facilitate access to information about Arthritis, Rheumatology and Autoimmune Diseases.

ANRF Conference Recap From Q4

ANRF continues to maintain an assertive presence at national and international meetings and conferences. Below are links to three brief roundups.

Dr. Nigrovic Puts Research Into Practice

This edition of our Alumni Spotlight shines light into the world of juvenile idiopathic arthritis with Dr. Nigrovic and how the patients often inspire the work done in the lab.